Vellum Health: Revolutionizing Mobile IV Care with Series A Funding
June 27, 2025, 7:32 pm
In the ever-evolving landscape of healthcare, Vellum Health emerges as a beacon of innovation. Based in Austin, Texas, this mobile healthcare platform has recently secured Series A funding, marking a significant leap forward in its mission to deliver advanced intravenous (IV) services directly to patients. With a fresh infusion of capital led by FCA Venture Partners, Vellum Health is poised to transform how IV therapy is administered, making it more accessible and efficient.
Vellum Health is not just another healthcare startup. It represents a paradigm shift in patient care. The company specializes in mobile IV access, infusion therapy, and on-site transfusion services. Imagine a world where patients receive complex care in the comfort of their homes or at skilled nursing facilities, bypassing the need for hospitalization. This is the vision Vellum Health is bringing to life.
The recent funding round, which also saw participation from Green Park & Golf Ventures and angel investors from previous rounds, is a testament to the confidence investors have in Vellum's model. The capital will be used to accelerate expansion into new markets and enhance its proprietary AI-powered technology platform. This platform is the backbone of Vellum's operations, enabling seamless integration with electronic medical records (EMR), intelligent care navigation, and proactive patient identification. It acts as the connective tissue between healthcare providers, payors, and clinical teams, ensuring that care is not just delivered but optimized.
Vellum Health's CEO, Tyler Payne, emphasizes the importance of this funding. It’s not just about growth; it’s about redefining care delivery. The company’s model is designed to reduce unnecessary hospitalizations while improving patient outcomes. By extending high-quality care into lower-cost settings, Vellum Health is addressing a critical need in the healthcare system.
The healthcare landscape is changing. Patients are demanding more convenience and accessibility. Vellum Health is answering that call. The company’s services include mobile IV access, on-demand infusions for hydration, infection, cognition, and nutrition, as well as on-site blood transfusions. This comprehensive approach ensures that patients receive the care they need, when they need it, without the burdensome logistics of traditional hospital visits.
The launch of the Vellum Health brand is another significant milestone. It unifies a portfolio of acquired vascular access companies into a single, tech-enabled care delivery platform. This consolidation not only streamlines operations but also enhances the overall patient experience. Patients can expect a seamless journey from diagnosis to treatment, all facilitated by cutting-edge technology and highly trained clinicians.
Vellum Health’s approach is patient-centered and mobile-first. This is not just a trend; it’s a necessity in today’s healthcare environment. As the industry grapples with rising costs and an aging population, solutions like Vellum Health’s are crucial. They provide a lifeline to patients who require complex care but wish to avoid the hospital setting.
The support from FCA Venture Partners is significant. Their expertise in healthcare investments brings valuable insights and connections that can accelerate Vellum Health’s growth. The firm’s managing partner, Matt King, recognizes the operational and clinical challenges Vellum is addressing. He believes the company is uniquely positioned to meet the needs of an evolving healthcare landscape.
Vellum Health is already making waves across multiple states, partnering with payors, hospitals, and post-acute care providers. This collaborative approach ensures that patients have access to complex care without the need for hospitalization. It’s a win-win situation: patients receive timely treatment, and healthcare systems can alleviate some of the burdens on their resources.
The healthcare industry is notorious for its slow adoption of technology. However, Vellum Health is breaking that mold. By integrating advanced technology with clinical expertise, the company is setting a new standard for care delivery. The AI-powered care coordination system not only enhances efficiency but also improves patient safety. This is the future of healthcare—smart, efficient, and patient-focused.
As Vellum Health prepares for its next phase of growth, the potential impact on the healthcare system is immense. The company is not just offering a service; it’s reshaping the entire care delivery model. By prioritizing convenience and quality, Vellum Health is paving the way for a new era in healthcare.
In conclusion, Vellum Health stands at the forefront of a healthcare revolution. With its recent Series A funding, the company is ready to scale its operations and enhance its technology platform. The vision is clear: to deliver high-quality, mobile IV care that meets the needs of patients where they are. As the healthcare landscape continues to evolve, Vellum Health is a shining example of how innovation can lead to better outcomes for all. The journey has just begun, and the future looks bright.
Vellum Health is not just another healthcare startup. It represents a paradigm shift in patient care. The company specializes in mobile IV access, infusion therapy, and on-site transfusion services. Imagine a world where patients receive complex care in the comfort of their homes or at skilled nursing facilities, bypassing the need for hospitalization. This is the vision Vellum Health is bringing to life.
The recent funding round, which also saw participation from Green Park & Golf Ventures and angel investors from previous rounds, is a testament to the confidence investors have in Vellum's model. The capital will be used to accelerate expansion into new markets and enhance its proprietary AI-powered technology platform. This platform is the backbone of Vellum's operations, enabling seamless integration with electronic medical records (EMR), intelligent care navigation, and proactive patient identification. It acts as the connective tissue between healthcare providers, payors, and clinical teams, ensuring that care is not just delivered but optimized.
Vellum Health's CEO, Tyler Payne, emphasizes the importance of this funding. It’s not just about growth; it’s about redefining care delivery. The company’s model is designed to reduce unnecessary hospitalizations while improving patient outcomes. By extending high-quality care into lower-cost settings, Vellum Health is addressing a critical need in the healthcare system.
The healthcare landscape is changing. Patients are demanding more convenience and accessibility. Vellum Health is answering that call. The company’s services include mobile IV access, on-demand infusions for hydration, infection, cognition, and nutrition, as well as on-site blood transfusions. This comprehensive approach ensures that patients receive the care they need, when they need it, without the burdensome logistics of traditional hospital visits.
The launch of the Vellum Health brand is another significant milestone. It unifies a portfolio of acquired vascular access companies into a single, tech-enabled care delivery platform. This consolidation not only streamlines operations but also enhances the overall patient experience. Patients can expect a seamless journey from diagnosis to treatment, all facilitated by cutting-edge technology and highly trained clinicians.
Vellum Health’s approach is patient-centered and mobile-first. This is not just a trend; it’s a necessity in today’s healthcare environment. As the industry grapples with rising costs and an aging population, solutions like Vellum Health’s are crucial. They provide a lifeline to patients who require complex care but wish to avoid the hospital setting.
The support from FCA Venture Partners is significant. Their expertise in healthcare investments brings valuable insights and connections that can accelerate Vellum Health’s growth. The firm’s managing partner, Matt King, recognizes the operational and clinical challenges Vellum is addressing. He believes the company is uniquely positioned to meet the needs of an evolving healthcare landscape.
Vellum Health is already making waves across multiple states, partnering with payors, hospitals, and post-acute care providers. This collaborative approach ensures that patients have access to complex care without the need for hospitalization. It’s a win-win situation: patients receive timely treatment, and healthcare systems can alleviate some of the burdens on their resources.
The healthcare industry is notorious for its slow adoption of technology. However, Vellum Health is breaking that mold. By integrating advanced technology with clinical expertise, the company is setting a new standard for care delivery. The AI-powered care coordination system not only enhances efficiency but also improves patient safety. This is the future of healthcare—smart, efficient, and patient-focused.
As Vellum Health prepares for its next phase of growth, the potential impact on the healthcare system is immense. The company is not just offering a service; it’s reshaping the entire care delivery model. By prioritizing convenience and quality, Vellum Health is paving the way for a new era in healthcare.
In conclusion, Vellum Health stands at the forefront of a healthcare revolution. With its recent Series A funding, the company is ready to scale its operations and enhance its technology platform. The vision is clear: to deliver high-quality, mobile IV care that meets the needs of patients where they are. As the healthcare landscape continues to evolve, Vellum Health is a shining example of how innovation can lead to better outcomes for all. The journey has just begun, and the future looks bright.